Cargando…

Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance

Impaired glucose tolerance (IGT) increases cardiovascular risk and can enlarge myocardial infarction (MI) incidence and severity. There is lack of information about cardioprotective potential of glucose-lowering drugs in IGT. We aimed to evaluate the sustainability of myocardium to ischemia–reperfus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simanenkova, Anna, Minasian, Sarkis, Karonova, Tatiana, Vlasov, Timur, Timkina, Natalya, Shpilevaya, Oksana, Khalzova, Aleksandra, Shimshilashvili, Anzhelika, Timofeeva, Valeria, Samsonov, Daniil, Borshchev, Yury, Galagudza, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987997/ https://www.ncbi.nlm.nih.gov/pubmed/33758265 http://dx.doi.org/10.1038/s41598-021-86132-2

Ejemplares similares

Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome
por: Ermolenko, Elena, et al.
Publicado: (2022)

Effects of tetracycline on myocardial infarct size in obese rats with chemically-induced colitis
por: Borshchev, Yury Yu, et al.
Publicado: (2019)

Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution
por: Minasian, Sarkis M, et al.
Publicado: (2013)

Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis
por: Borshchev, Yury Y., et al.
Publicado: (2022)

The Effect of Metformin on the Myocardial Tolerance to Ischemia-Reperfusion Injury in the Rat Model of Diabetes Mellitus Type II
por: Kravchuk, Ekaterina, et al.
Publicado: (2011)

Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs
por: Kondratov, Kirill, et al.
Publicado: (2016)

Effect of Physical Training on the Morphology of Parasympathetic Atrial Ganglia after Unilateral Vagotomy in Rats
por: Mamontov, Oleg V., et al.
Publicado: (2022)

The Effect of Probiotic Strains on Myocardial Infarction Size, Biochemical and Immunological Parameters in Rats with Systemic Inflammatory Response Syndrome and Polymorbidity
por: Borshchev, Yu. Yu., et al.
Publicado: (2022)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Argun, Mustafa, et al.
Publicado: (2016)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Tseng, Yi-Tang
Publicado: (2016)

Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells
por: Lu, Ran, et al.
Publicado: (2018)

The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018)

Metformin mediates cardioprotection against aging‐induced ischemic necroptosis
por: Li, Chen, et al.
Publicado: (2020)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Gut microbiome differences between metformin‐ and liraglutide‐treated T2DM subjects
por: Wang, Zhang, et al.
Publicado: (2017)

Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model
por: Kristensen, Jens, et al.
Publicado: (2009)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
por: Jensterle, Mojca, et al.
Publicado: (2017)

Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials
por: Izmailov, Timur, et al.
Publicado: (2023)

Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways
por: AlAsmari, Abdullah F., et al.
Publicado: (2020)

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19
por: Karonova, Tatiana L., et al.
Publicado: (2021)

Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
por: McLean, Brent A., et al.
Publicado: (2022)

The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials
por: Gu, Jianqiu, et al.
Publicado: (2016)

Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease
por: Liu, Ying, et al.
Publicado: (2017)

Metformin exerts synergistic anti-proliferative effects with liraglutide in human umbilical vein endothelial cells (HUVECs)
por: Shadboorestan, Amir, et al.
Publicado: (2022)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway
por: Ke, Jing, et al.
Publicado: (2017)

Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model
por: Oidor-Chan, Víctor Hugo, et al.
Publicado: (2016)

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
por: Davies, M J, et al.
Publicado: (2012)

A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report
por: Khandalavala, Birgit N.
Publicado: (2017)

Liraglutide – Indian Experience
por: Anirban, Majumder, et al.
Publicado: (2018)

Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
por: Kapitza, C, et al.
Publicado: (2013)

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
por: Zhao, Xu, et al.
Publicado: (2019)

Carbohydrate restricted diet in conjunction with metformin and liraglutide is an effective treatment in patients with deteriorated type 2 diabetes mellitus: Proof-of-concept study
por: Müller, Jürgen E, et al.
Publicado: (2011)

Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes: A systematic review and meta-analysis
por: Li, Mingxing, et al.
Publicado: (2017)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide
por: Matić, Anita, et al.
Publicado: (2021)

Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States
por: Langer, Jakob, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s2uh5puvbsisduaonp993a02js